Deal Making

Featured on Deal Making

Vir and GSK add CDMO Samsung Bio to COVID-19 MAb program in $362m deal
Deal-Making
Vir and GSK add CDMO Samsung Bio to COVID-19 MAb program in $362m dealVir and GSK add CDMO Samsung Bio to COVID-19 MAb program in $362m deal

Samsung Biologics becomes the latest CDMO to support Vir’s SARS-CoV-2 monoclonal antibody (MAb) programs.

byDan Stanton, Editorial director
Apr 13, 2020
|
3 Min Read
Establish gene therapy tech early says Daiichi as it inks Ultragenyx deal
Deal-Making
Establish gene therapy tech early says Daiichi as it inks Ultragenyx dealEstablish gene therapy tech early says Daiichi as it inks Ultragenyx deal
byGareth Macdonald
Apr 9, 2020
2 Min Read
Allogene turns to MaxCyte’s tech for its off-the-shelf CAR-T therapies
Therapeutic Class
Allogene turns to MaxCyte’s tech for its off-the-shelf CAR-T therapiesAllogene turns to MaxCyte’s tech for its off-the-shelf CAR-T therapies
byDan Stanton
Apr 3, 2020
2 Min Read
J&J to expand vaccine capacity as part of $1bn BARDA coronavirus collaboration
Global Markets
J&J to expand vaccine capacity as part of $1bn BARDA coronavirus collaborationJ&J to expand vaccine capacity as part of $1bn BARDA coronavirus collaboration
byDan Stanton
Apr 1, 2020
2 Min Read
Cytiva rises out of GE Healthcare as Danaher completes $21bn deal
Deal-Making
Cytiva rises out of GE Healthcare as Danaher completes $21bn dealCytiva rises out of GE Healthcare as Danaher completes $21bn deal
byDan Stanton
Apr 1, 2020
3 Min Read
Translate Bio, Sanofi secure CDMO capacity for potential COVID-19 mRNA vaccine
Facilities & Capacity
Translate Bio, Sanofi secure CDMO capacity for potential COVID-19 mRNA vaccineTranslate Bio, Sanofi secure CDMO capacity for potential COVID-19 mRNA vaccine
byDan Stanton
Mar 31, 2020
3 Min Read

More from Deal Making

Wuxi Biologics signs R&D license for fungal expression tech
Deal-Making
Wuxi Biologics signs R&D license for fungal expression tech
Wuxi Biologics signs R&D license for fungal expression tech
Mar 31, 2020
|
2 Min Read
byGareth Macdonald
Later in-licensing deals impacting biopharma CDMOs, says expert
Deal-Making
Later in-licensing deals impacting biopharma CDMOs, says expert
Later in-licensing deals impacting biopharma CDMOs, says expert
Mar 27, 2020
|
2 Min Read
byGareth Macdonald
Danaher closes in on $21bn GE takeover after FTC approval
Upstream & Downstream Processing
Danaher closes in on $21bn GE takeover after FTC approval
Danaher closes in on $21bn GE takeover after FTC approval
Mar 23, 2020
|
2 Min Read
byGareth Macdonald
Juno hires Oxford Biomedica for vectors, platform and OxBox
Deal-Making
Juno hires Oxford Biomedica for vectors, platform and OxBox
Juno hires Oxford Biomedica for vectors, platform and OxBox
Mar 18, 2020
|
2 Min Read
byGareth Macdonald
One billion doses: CureVac gains $88m to support capacity for COVID-19 mRNA vaccine
Global Markets
One billion doses: CureVac gains $88m to support capacity for COVID-19 mRNA vaccine
One billion doses: CureVac gains $88m to support capacity for COVID-19 mRNA vaccine
Mar 18, 2020
|
4 Min Read
byDan Stanton, Editorial director
MilliporeSigma: Thermo Fisher’s Qiagen buy ‘no threat’ to bioprocess landscape
Upstream & Downstream Processing
MilliporeSigma: Thermo Fisher’s Qiagen buy ‘no threat’ to bioprocess landscape
MilliporeSigma: Thermo Fisher’s Qiagen buy ‘no threat’ to bioprocess landscape
Mar 10, 2020
|
2 Min Read
byDan Stanton, Editorial director
Trouble choosing? BrevisRefero launches CDMO proposal platform
Deal-Making
Trouble choosing? BrevisRefero launches CDMO proposal platform
Trouble choosing? BrevisRefero launches CDMO proposal platform
Mar 9, 2020
|
2 Min Read
byDan Stanton, Editorial director
Samsung Bio lands MAb development contract with STCube
Deal-Making
Samsung Bio lands MAb development contract with STCube
Samsung Bio lands MAb development contract with STCube
Mar 9, 2020
|
2 Min Read
byGareth Macdonald
Thermo’s $11.5bn bid for Qiagen accepted
Deal-Making
Thermo’s $11.5bn bid for Qiagen accepted
Thermo’s $11.5bn bid for Qiagen accepted
Mar 4, 2020
|
2 Min Read
byGareth Macdonald
Gilead: $4.9bn Forty Seven buy sits in the oncology ‘sweet spot’
Bioprocess Insider
Gilead: $4.9bn Forty Seven buy sits in the oncology ‘sweet spot’
Gilead: $4.9bn Forty Seven buy sits in the oncology ‘sweet spot’
Mar 4, 2020
|
2 Min Read
byBPI Staff
Fujifilm breaks ground at $54m NC biologics plant expansion
Deal-Making
Fujifilm breaks ground at $54m NC biologics plant expansion
Fujifilm breaks ground at $54m NC biologics plant expansion
Feb 26, 2020
|
2 Min Read
byDan Stanton, Editorial director
Another WuXi Vaccines deal? No, just a repurposed press release
Deal-Making
Another WuXi Vaccines deal? No, just a repurposed press release
Another WuXi Vaccines deal? No, just a repurposed press release
Feb 21, 2020
|
2 Min Read
byDan Stanton, Editorial director
KKR pumps €50m into Univercells through Gamma funding platform
Upstream & Downstream Processing
KKR pumps €50m into Univercells through Gamma funding platform
KKR pumps €50m into Univercells through Gamma funding platform
Feb 19, 2020
|
3 Min Read
byDan Stanton, Editorial director
Co.don wins MukoCell contract to make urology cell therapy
Deal-Making
Co.don wins MukoCell contract to make urology cell therapy
Co.don wins MukoCell contract to make urology cell therapy
Feb 14, 2020
|
2 Min Read
byGareth Macdonald
Charles River eyeing up HemaCare expansion and more CGT acquisitions
Deal-Making
Charles River eyeing up HemaCare expansion and more CGT acquisitions
Charles River eyeing up HemaCare expansion and more CGT acquisitions
Feb 13, 2020
|
3 Min Read
byDan Stanton, Editorial director
Catalent’s $315m Masthercell buy: Frothy exuberance or the new CMO norm?
Deal-Making
Catalent’s $315m Masthercell buy: Frothy exuberance or the new CMO norm?
Catalent’s $315m Masthercell buy: Frothy exuberance or the new CMO norm?
Feb 12, 2020
|
2 Min Read
byDan Stanton, Editorial director
Catalent to buy Orgenesis’ cell therapy CDMO biz for $315m
Deal-Making
Catalent to buy Orgenesis’ cell therapy CDMO biz for $315m
Catalent to buy Orgenesis’ cell therapy CDMO biz for $315m
Feb 3, 2020
|
3 Min Read
byDan Stanton, Editorial director
Takeda divesting former-Shire $400m plant with 200 staff in Ireland
Business
Takeda divesting former-Shire $400m plant with 200 staff in Ireland
Takeda divesting former-Shire $400m plant with 200 staff in Ireland
Feb 3, 2020
|
2 Min Read
byDan Stanton, Editorial director
Ori: ‘Partnerships key to bring down cell therapy COGS’
Deal-Making
Ori: ‘Partnerships key to bring down cell therapy COGS’
Ori: ‘Partnerships key to bring down cell therapy COGS’
Jan 29, 2020
|
3 Min Read
byDan Stanton, Editorial director
Top 10 advanced therapy milestones of 2019: Patient access takes center stage
Global Markets
Top 10 advanced therapy milestones of 2019: Patient access takes center stage
Top 10 advanced therapy milestones of 2019: Patient access takes center stage
Jan 27, 2020
|
8 Min Read
byDan Stanton, Editorial director
Amgen thanks BMS-Celgene merger in creating China opportunity
Bioprocess Insider
Amgen thanks BMS-Celgene merger in creating China opportunity
Amgen thanks BMS-Celgene merger in creating China opportunity
Jan 15, 2020
|
2 Min Read
byDan Stanton, Editorial director
Waters adding automation lab tech by buying Andrew Alliance
Deal-Making
Waters adding automation lab tech by buying Andrew Alliance
Waters adding automation lab tech by buying Andrew Alliance
Jan 14, 2020
|
1 Min Read
byBPI Staff
Yposkesi to make Genethon and Sarepta’s DMD gene therapy
Deal-Making
Yposkesi to make Genethon and Sarepta’s DMD gene therapy
Yposkesi to make Genethon and Sarepta’s DMD gene therapy
Jan 13, 2020
|
2 Min Read
byGareth Macdonald
In with the new… Deal completions from Catalent, CRL and Janssen
Deal-Making
In with the new… Deal completions from Catalent, CRL and Janssen
In with the new… Deal completions from Catalent, CRL and Janssen
Jan 9, 2020
|
3 Min Read
byDan Stanton, Editorial director
Getinge pays $89m for Applikon to boost life sciences biz
Deal-Making
Getinge pays $89m for Applikon to boost life sciences biz
Getinge pays $89m for Applikon to boost life sciences biz
Jan 7, 2020
|
2 Min Read
byGareth Macdonald
Twist to biopharma with Pandion antibody optimization expansion
Deal-Making
Twist to biopharma with Pandion antibody optimization expansion
Twist to biopharma with Pandion antibody optimization expansion
Jan 6, 2020
|
2 Min Read
byDan Stanton, Editorial director
Lonza teams with 3D bioprinting firm Allevi
Deal-Making
Lonza teams with 3D bioprinting firm Allevi
Lonza teams with 3D bioprinting firm Allevi
Jan 2, 2020
|
2 Min Read
byGareth Macdonald
Biotech VC down 20% in US as policies drive away foreign investors, BIO
Deal-Making
Biotech VC down 20% in US as policies drive away foreign investors, BIO
Biotech VC down 20% in US as policies drive away foreign investors, BIO
Dec 31, 2019
|
4 Min Read
byDan Stanton, Editorial director
The 12 trends of Christmas: A look back at 2019
Deal-Making
The 12 trends of Christmas: A look back at 2019
The 12 trends of Christmas: A look back at 2019
Dec 20, 2019
|
4 Min Read
byGareth Macdonald
Novartis inks 5 years vector supply extension with Oxford Biomedica
Deal-Making
Novartis inks 5 years vector supply extension with Oxford Biomedica
Novartis inks 5 years vector supply extension with Oxford Biomedica
Dec 19, 2019
|
2 Min Read
byGareth Macdonald

Webinars

Ask the Expert webcasts
ATE Webcasts
Register Now: Big Impact from Small Samples: Harnessing High-Precision Tunable Laser Spectroscopy for Complex Bioprocessing Analysis
Register Now: Big Impact from Small Samples: Harnessing High-Precision Tunable Laser Spectroscopy for Complex Bioprocessing Analysis
Ask the Expert webcasts
ATE Webcasts
Register Now: Advancing mRNA and CircRNA-based Vaccines and Therapeutics in CMC: From Process Development to Analytics
Register Now: Advancing mRNA and CircRNA-based Vaccines and Therapeutics in CMC: From Process Development to Analytics
Insider News
See all
Jun 5 - Jun 6, 2024
Exploit Advances in Exosomes to Improve Efficiencies in Drug Delivery: Connect with senior-level executives and scientists who will share new data and novel case studies on advancing EV products through clinical stage towards commercialization
Learn More

Innovative Technology

Nagase Trehalose SG
Sponsored Content
Innovative Impurity Reduction in Harvesting Process With TREHALOSE SG
Innovative Impurity Reduction in Harvesting Process With TREHALOSE SG

Jan 9, 2025

Bruker Tornado Spectroscopy
Sponsored Content
Monitoring and Controlling Upstream Bioprocesses with Raman Spectroscopy
Monitoring and Controlling Upstream Bioprocesses with Raman Spectroscopy

Dec 1, 2024

Thermo Fisher White Paper
Sponsored Content
Peptones: A Powerful Tool for Manufacturing Complex Protein Therapies
Peptones: A Powerful Tool for Manufacturing Complex Protein Therapies

Nov 21, 2024

Subscribe to receive our monthly print or digital publication
Join our 70,000+ readers. And yes, it's completely free.
Subscribe